Sol-Gel (SLGL) Revenue & Revenue Breakdown
Sol-Gel Revenue Highlights
Latest Revenue (Y)
$1.55M
Latest Revenue (Q)
$466.00K
Sol-Gel Revenue by Period
Sol-Gel Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.55M | -59.98% |
2022-12-31 | $3.88M | -87.58% |
2021-12-31 | $31.27M | 256.54% |
2020-12-31 | $8.77M | -61.71% |
2019-12-31 | $22.90M | 17655.04% |
2018-12-31 | $129.00K | -25.86% |
2017-12-31 | $174.00K | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | - |
Sol-Gel Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $466.00K | 4.25% |
2023-12-31 | $447.00K | 109.86% |
2023-09-30 | $213.00K | -64.14% |
2023-06-30 | $594.00K | -21.64% |
2023-03-31 | $758.00K | 658.00% |
2022-12-31 | $100.00K | -61.69% |
2022-09-30 | $261.00K | -92.58% |
2022-06-30 | $3.52M | 117166.67% |
2022-03-31 | $3.00K | -99.99% |
2021-12-31 | $20.81M | 135.48% |
2021-09-30 | $8.84M | 852.16% |
2021-06-30 | $928.00K | 32.38% |
2021-03-31 | $701.00K | -65.92% |
2020-12-31 | $2.06M | -2.79% |
2020-09-30 | $2.12M | 86.76% |
2020-06-30 | $1.13M | -67.30% |
2020-03-31 | $3.46M | -13.81% |
2019-12-31 | $4.02M | -15.06% |
2019-09-30 | $4.73M | -39.27% |
2019-06-30 | $7.79M | 22.57% |
2019-03-31 | $6.36M | -318000.00% |
2018-12-31 | $-2.00K | -105.26% |
2018-09-30 | $38.00K | -22.45% |
2018-06-30 | $49.00K | 11.36% |
2018-03-31 | $44.00K | -74.71% |
2017-12-31 | $174.00K | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | - |
Sol-Gel Revenue Breakdown
Sol-Gel Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Jun 22 |
---|---|
Collabrations | - |
License | $3.52M |
Latest
Sol-Gel Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Jun 22 |
---|---|
Collabrations | - |
License | $3.52M |
Latest
Sol-Gel Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ADAG | Adagene | $18.11M | $833.34K |
JANX | Janux Therapeutics | $8.08M | $8.90M |
SLGL | Sol-Gel | $1.55M | $466.00K |
MNOV | MediciNova | $1.00M | - |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
ANTX | AN2 Therapeutics | - | - |
PHVS | Pharvaris | - | - |
AVTE | Aerovate Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
PEPG | PepGen | - | - |